These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22951844)

  • 21. [China cholesterol education program (CCEP) expert advice for the management of dyslipidaemias to reduce cardiovascular risk (2019)].
    ; ; ;
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):18-22. PubMed ID: 31887831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A commentary on the new ESC guidelines on dyslipidaemias.
    Drexel H
    Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):73-74. PubMed ID: 28363207
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future.
    Catapano AL; Ray KK; Tokgözoglu L
    Atherosclerosis; 2022 Jan; 340():51-52. PubMed ID: 34863532
    [No Abstract]   [Full Text] [Related]  

  • 24. A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?
    Dykun I; Mahabadi AA; Rassaf T
    Eur Heart J; 2020 Jun; 41(24):2331. PubMed ID: 32031601
    [No Abstract]   [Full Text] [Related]  

  • 25. [How to apply clinical guidelines in medical practice? The example of dyslipidemia].
    Pasche O; Pache S; Cornuz J; Darioli R; Rodondi N
    Rev Med Suisse; 2008 Mar; 4(148):662-5. PubMed ID: 18459662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarities and differences between European and United States guidelines for the management of dyslipidaemias.
    Reiner Ž
    Kardiol Pol; 2015; 73(7):471-7. PubMed ID: 26189467
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of dyslipidaemia - evidence and practical recommendations.
    Nestel PJ; O'Brien R; Nelson M
    Aust Fam Physician; 2008 Jul; 37(7):521-7. PubMed ID: 18592069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dyslipidemia management for secondary prevention in cardiovascular disease: from guidelines to clinical practice].
    Mattesini A; Masiero G; Barbieri L; Vizzari G; Tarantino F; La Manna A; Mauro C; Limbruno U; Rigattieri S; Castiglioni B; Marchese A; Musumeci G; Tarantini G
    G Ital Cardiol (Rome); 2019 Sep; 20(9 Suppl 1):44S-49S. PubMed ID: 31593190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines.
    Lüscher TF
    Eur Heart J; 2016 Oct; 37(39):2963-2965. PubMed ID: 27923852
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dyslipidaemia and vascular risk. A new evidence based review].
    Pallarés-Carratalá V; Pascual-Fuster V; Godoy-Rocatí D
    Semergen; 2015; 41(8):435-45. PubMed ID: 25559484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Update Dyslipidaemias - Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
    Sinning D; Landmesser U
    Dtsch Med Wochenschr; 2017 Jun; 142(11):816-820. PubMed ID: 28564733
    [No Abstract]   [Full Text] [Related]  

  • 33. Do we need a redefinition of the cardiovascular risk categories used in the 2019 ESC/EAS guidelines on dyslipidaemias?
    Gragnano F; Calabrò P
    Eur Heart J; 2020 Jun; 41(24):2332. PubMed ID: 32031600
    [No Abstract]   [Full Text] [Related]  

  • 34. [Management of cardiovascular diseases in adults from 1999 to 2014: what has really changed?].
    Barthel C; Nanchen D; Jornayvaz FR; Wuerzner G; Senn N
    Rev Med Suisse; 2015 Nov; 11(496):2228, 2230-5. PubMed ID: 26742353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].
    Lucchi T; Vergani C
    G Ital Cardiol (Rome); 2014 Mar; 15(3):149-60. PubMed ID: 24770428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of laboratory and lipid profile evaluation: A call for action with a special focus in 2016 ESC/EAS dyslipidaemia guidelines - Full report.
    da Silva PM; Duarte JS; von Hafe P; Gil V; de Oliveira JN; de Sousa G
    Atheroscler Suppl; 2018 Jun; 31():e1-e12. PubMed ID: 29859563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol Guidelines: More Similar Than Different.
    Pokharel Y; Akeroyd JM; Virani SS
    Prog Cardiovasc Dis; 2016; 59(2):190-199. PubMed ID: 27497507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias.
    Pérez de Isla L; ; Pérez de Isla L; Fernández PLS; Álvarez-Sala Walther L; Barrios Alonso V; Castro Conde A; Galve Basilio E; García Ortiz L; Mata López P; ; Alegría Ezquerra E; Cordero Fort A; Cosin Sales J; Escobar Cervantes C; García-Moll Marimón X; José Gómez Doblas J; Marzal Martín D; Murga Eizagaechevarria N; de Pablo Zarzosa C; Miguel Rincón L; Sanchis Forés J; ; Alberto San Román Calvar J; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marín Ortuño F; Pérez de Isla L; Rodríguez Padial L; Luis Sánchez Fernández P; Sionis Green A; Vázquez García R
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):72-77. PubMed ID: 28131410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.